Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients

被引:0
|
作者
Gao, Xiang [1 ]
Jin, Xiaowei [1 ]
Huang, Rui [1 ]
Li, Zhenxing [1 ]
Zhang, Hanle [2 ]
Fan, Pei [1 ]
机构
[1] Wenzhou Med Univ, Yuying Childrens Hosp, Dept Orthoped, Affiliated Hosp 2, 109 Xueyuan West Rd, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Affiliated Hosp 2, Dept Rehabil, Wenzhou, Zhejiang, Peoples R China
关键词
Deep vein Thromboembolism; Nadroparin; Fondaparinux Sodium; Total hip arthroplasty; Total knee arthroplasty; VENOUS THROMBOEMBOLISM; ENOXAPARIN; PROPHYLAXIS; THROMBOSIS; SURGERY;
D O I
10.1186/s12893-024-02440-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives To compare the efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism (DVT) in lower extremities after total hip arthroplasty (THA) and total knee arthroplasty (TKA). Methods A total of 592 patients were enrolled in the study. Clinical data of patients who underwent total hip arthroplasty (THA) and total knee arthroplasty (TKA) in our hospital from December 2021 to September 2022 were retrospectively collected, which mainly included patients' general information, surgery-related information, and DVT-related information. The patients were categorized into the nadroparin group(n = 278) and the fondaparinux sodium group(n = 314) according to the types of anticoagulants used. Anticoagulant therapy began 12-24 h after operation and continued until discharge. DVT prevalence between two groups was compared. The Statistical Package for Social Sciences (SPSS) software version 25 (SPSS, Armonk, NY, USA) was used for statistical analysis. Results The prevalence of DVT in the nadroparin group and the fondaparinux sodium group was 8.3% (23/278) and 15.0% (47/314), respectively(p = 0.012). Statistical analysis showed that nadroparin group showed a lower prevalence of thrombosis than fondaparinux group (OR = 1.952, P = 0.012). Subgroup analyses showed that nadroparin group had a lower prevalence of DVT than fondaparinux group in some special patients groups such as female patients (OR = 2.258, P = 0.007), patients who are 65-79 years old (OR = 2.796, P = 0.004), patients with hypertension (OR = 2.237, P = 0.042), patients who underwent TKA (OR = 2.091, P = 0.011), and patients who underwent combined spinal-epidural anesthesia (OR = 2.490, P = 0.003) (P < 0.05). Conclusion Nadroparin may have an advantage over fondaparinux sodium in preventing DVT in lower extremities after THA and TKA.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Impact of Chronic Kidney Disease on Deep Vein Thrombosis after Total Hip and Total Knee Arthroplasty
    Mitsuhashi, Takayuki
    Gohbara, Masaomi
    Kasuya, Fukashi
    Shigemasa, Tomohiko
    CIRCULATION, 2010, 122 (21)
  • [32] Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty A meta-analysis
    Wolowacz, Sorrel E.
    Roskell, Neil S.
    Plumb, Jonathan M.
    Caprini, Joseph A.
    Eriksson, Bengt I.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 77 - 85
  • [33] Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty
    Stern, SH
    Wixson, RL
    O'Connor, D
    JOURNAL OF ARTHROPLASTY, 2000, 15 (02) : 153 - 158
  • [34] Cemented and hybrid total hip arthroplasty lead to lower blood loss in primary total hip arthroplasty: a retrospective study
    Meissner, Nils
    Halder, Andreas M.
    Schrednitzki, Daniel
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2023, 143 (10) : 6447 - 6451
  • [35] Gender differences of venous thromboembolism risk after total hip and total knee arthroplasty: a meta-analysis
    Yue Lu
    Zhen-Yu Zhou
    Ya-Ke Liu
    Hong-Lin Chen
    Hui-Lin Yang
    Fan Liu
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 556 - 562
  • [36] Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty A protocol for meta-analysis
    Le, Guoping
    Yang, Chengzhi
    Zhang, Ming
    Xi, Licheng
    Luo, Hanwen
    Tang, Jingli
    Zhao, Jinmin
    MEDICINE, 2020, 99 (49) : E23055
  • [37] Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty
    Mochizuki, Takeshi
    Ikari, Katsunori
    Yano, Koichiro
    Hiroshima, Ryo
    Ishibashi, Mina
    Okazaki, Ken
    MODERN RHEUMATOLOGY, 2019, 29 (04) : 682 - 686
  • [38] Mortality rate after total knee arthroplasty or total hip arthroplasty in patients with a history of liver transplant
    Rodriguez-Merchan, E. Carlos
    WORLD JOURNAL OF ORTHOPEDICS, 2024, 15 (04): : 310 - 311
  • [39] Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplasty
    Yohei Yukizawa
    Yutaka Inaba
    Shin-ichiro Watanabe
    Satoshi Yajima
    Naomi Kobayashi
    Takashi Ishida
    Naoyuki Iwamoto
    Choe Hyonmin
    Mashio Nakamura
    Tomoyuki Saito
    Journal of Thrombosis and Thrombolysis, 2012, 34 : 526 - 532
  • [40] Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplasty
    Yukizawa, Yohei
    Inaba, Yutaka
    Watanabe, Shin-ichiro
    Yajima, Satoshi
    Kobayashi, Naomi
    Ishida, Takashi
    Iwamoto, Naoyuki
    Hyonmin, Choe
    Nakamura, Mashio
    Saito, Tomoyuki
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (04) : 526 - 532